Condition
Leukomalacia Periventricular
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Unknown2
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01203501Completed
In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
NCT02082535Unknown
S100B as a Marker of Brain Injury of Preterm Infants
NCT00910234Phase 1Unknown
Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants
NCT00369005Not ApplicableCompleted
Liberal Versus Restrictive Transfusion Guidelines for Preterm Infants
Showing all 4 trials